Wendy Murray
Psychiatric/Mental Health · Cedar Rapids, IANPI 1215665930
Payments from drug & device makers
Across 135 payments — averaging $16.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$410
- Teva Pharmaceuticals USA, Inc.$362
- Otsuka America Pharmaceutical, Inc.$285
- Neurocrine Biosciences, Inc.$257
- E.r. Squibb & Sons, L.L.C.$233
- Alkermes, Inc.$211
- plus $482 from 9 others
What the payments were for
- Food & beverage$2,13095%
- Education$1115%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $410 |
| Teva Pharmaceuticals USA, Inc. | 13 | $362 |
| Otsuka America Pharmaceutical, Inc. | 15 | $285 |
| Neurocrine Biosciences, Inc. | 27 | $257 |
| E.r. Squibb & Sons, L.L.C. | 12 | $233 |
| Alkermes, Inc. | 11 | $211 |
| Axsome Therapeutics, Inc. | 6 | $173 |
| Supernus Pharmaceuticals, Inc. | 1 | $84 |
| Johnson & Johnson | 4 | $69 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $62 |
| Almatica Pharma LLC | 2 | $29 |
| Merck | 1 | $18 |
| Corium, LLC | 1 | $17 |
| Lundbeck LLC | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
How this compares
$2,241 in reported general payments places this provider in the 70th percentile of 443 psychiatric/mental health providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 119 | $167,405 |
| IngrezzaValbenazine Tosylate | 12 | $100,127 |
| Invega SustennaPaliperidone Palmitate | 23 | $79,263 |
| Abilify MaintenaAripiprazole | 27 | $75,553 |
| AustedoDeutetrabenazine | 13 | $64,502 |
| CaplytaLumateperone Tosylate | 17 | $27,247 |
| RexultiBrexpiprazole | 14 | $17,795 |
| QuviviqDaridorexant Hcl | 22 | $12,040 |
| VyvanseLisdexamfetamine Dimesylate | 27 | $10,529 |
| TrintellixVortioxetine Hydrobromide | 13 | $8,624 |
| Hydroxyzine Hcl | 79 | $3,592 |
| Duloxetine Hcl | 140 | $2,953 |
| Buspirone Hcl | 180 | $2,508 |
| Triazolam | 13 | $2,474 |
| Bupropion XlBupropion Hcl | 241 | $2,341 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $410 | $167,405119 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $257 | $100,12712 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $285 | $93,34841 claims |
| Johnson & JohnsonInvega Sustenna | $69 | $79,26323 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $362 | $64,50213 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $62 | $27,24717 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $13 | $12,04022 claims |
| Almatica Pharma LLCSertraline Hcl | $29 | $633157 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 443 psychiatric/mental health providers in Iowa.
Other psychiatric/mental health in Cedar Rapids
- Jennifer BradleyCedar Rapids$66K
- Amy MorinCedar Rapids$24K
- Abbie KelleyCedar Rapids$7K
- Natasha LashCedar Rapids$6K
- Kristina GatesCedar Rapids$6K
- Daniell DarbyshireCedar Rapids$5K
- Tarrah HollidayAtlantic$421K
- Kelsie SwisherParkersburg$235K
- Kama AusbornWaterloo$64K
- Quentin ChambersDes Moines$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.